A common painkiller associated with menstrual cramps could be a tool to reversing memory loss caused by Alzheimer’s disease, researchers assert.
Psychiatrist gets 9 months in prison for nursing home drug kickback scheme
By
Mar 15, 2016
A Chicago psychiatrist who prescribed the antipsychotic clozapine to thousands of nursing home residents in exchange for kickbacks was sentenced to 9 months in prison on Friday.
Senate panel digs into drug pricing
By
Nov 05, 2015
An investigation into pharmaceutical drug pricing has been launched following the widely-publicized, steep price increases of certain drugs, the Senate’s Special Committee on Aging announced Wednesday.
FDA to beef up warnings on opioid painkillers
By
Mar 24, 2016
Labels for certain opioid pain medications will soon be required to carry a warning about the drugs’ risks of misuse and death, the U.S. Food and Drug Administration announced Tuesday.
4-in-1 flu shot shows promise
By
Dec 06, 2017
A vaccine that combines genes from four strains of influenza may one day serve as a universal flu shot, researchers said in November.
Omnicare to pay $8 million to settle false claims allegations
By
May 18, 2017
Long-term care pharmacy giant Omnicare agreed on Tuesday to pay $8 million to clear up allegations that it used an automated system to submit false claims to Medicare and Medicaid.
4-in-1 flu vaccine to provide lifelong coverage?
By
Nov 03, 2017
New research shows a vaccine combining genes from four strains of influenza may one day prevail as a universal flu shot.
‘Intensive’ blood pressure treatment benefits seniors, won’t increase fall risk
By
May 23, 2016
Increasing the level of blood pressure therapy for older adults can reduce their risk of heart disease without raising fall risk, a new study has found.
Common painkiller may help reverse Alzheimer’s-related memory loss
By
Aug 15, 2016
An anti-inflammatory drug commonly used to treat pain associated from menstrual cramps may be able to reverse memory loss linked to Alzheimer’s disease, new research shows.
Omnicare settles kickback, FCA cases for $31 million
By
Jul 06, 2017
Long-term care pharmacy giant Omnicare agreed to pay a total of $31 million in May to settle allegations it submitted false claims and accepted kickbacks to promote certain drugs.